Clinical Trials & Research Studies
Breast cancer clinical trials, also called clinical studies, are a type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis or treatment.
In this section, get basic information about breast cancer clinical trials for women diagnosed with triple-negative breast cancer, explore whether taking part in a clinical trial is right for you and find studies you may be eligible to participate in.
You can also get information and updates on other breast cancer research studies that follow participants over time to determine treatment outcomes.
Trial Examines PARP Inhibitors in Triple-Negative Cancers
If you are affected by triple-negative breast cancer or have HER2 negative breast cancer with BRCA1/2 mutations, find out if you are eligible to participate in this trial, which is considering the impact of rucaparib, a PARP inhibitor on stages I-III breast cancer.
